Munich Re Puts Margins Ahead of Top-Line Growth as Currency Headwinds Bite

Munich Re walked away from roughly one-fifth of its renewal business in April, a deliberate sacrifice of volume that underscores the group’s determination to defend underwriting margins even as a strengthening euro erodes the value of its dollar-denominated earnings. The combined pressure has left one of Europe’s largest reinsurers with a buoyant profit picture but a stock that continues to slide.

At the 1 April renewal, the risk-adjusted price level fell 3.1% and the volume of business written dropped 18.5%. The company made no apology for the pullback: contracts that failed to meet internal return hurdles were simply not renewed. The discipline protects profitability in the property-casualty segment, but it also hands market share to competitors at a time when a benign claims environment is already softening rates.

The currency dimension adds a second layer of drag. Munich Re earns a large share of premiums and investment income in US dollars but reports in euros. Since the start of the year the euro has climbed from around $1.03 into a $1.15–$1.20 range, inflating the value of the common currency and deflating the translation of dollar receipts. In the first quarter, reported insurance revenue dipped 5% to €15.018 billion, even though the underlying business volume stayed broadly stable.

Should investors sell immediately? Or is it worth buying Münchener Rück?

Behind those top-line figures, however, the operating engine is humming. Net profit jumped to €1.714 billion in the opening quarter from €1.094 billion a year earlier, pushing the return on equity to 19.7%. The capital position remains exceptionally solid: the Solvency II ratio stood at 292% after deducting the buyback programme that was already in train.

That programme, announced in late April, authorises the repurchase of up to €2.25 billion of shares, all of which will be cancelled. The first tranche, worth as much as €900 million, began on 14 May and is scheduled to run until 21 August 2026. It represents roughly 1.5% of the share capital, but so far it has done little to steady the stock. The shares closed at €487.50 on Monday, having lost 14.05% over the preceding 30 days. By Tuesday they had slipped further to €485.20, taking the year-to-date decline to 11.62%. The stock now trades 9.63% below its 200-day moving average.

Management is also attacking costs. The company aims for recurring annual savings of around €600 million by 2030, with €200 million of that targeted for 2026. More than 300 AI applications have been identified or launched. At the ERGO subsidiary, roughly 200 positions are expected to be eliminated each year through 2030, amounting to about 1,000 job cuts in total, to be achieved via natural attrition, phased retirement and severance packages.

The confluence of currency pressure and pricing softness has created a rare disconnect between operational strength and market sentiment. The group still forecasts full-year 2026 insurance revenue of around €64 billion and net profit of roughly €6.3 billion – targets the board has so far left unchanged. The July renewal round will be the next test: stable pricing would ease some of the strain, while a persistently strong euro would keep the gap between bottom-line performance and share-price performance wide open.

Ad

Münchener Rück Stock: New Analysis - 19 May

Fresh Münchener Rück information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Münchener Rück analysis...

en | DE0008430026 | MUNICH | boerse | 69374954 |